Glenn Vraniak

Director/Miembro de la Junta en

Apollomics, Inc. (United States)

63 años

39 relaciones

Health Technology

Finance

Producer Manufacturing

Perfil

Glenn S.
Vraniak is the founder of Perceptus.
Current job includes Independent Director at Apollomics, Inc. since 2023.
Former jobs include Independent Director at Apollomics, Inc., President at Aprecia Pharmaceuticals Co. from 2011 to 2013, Executive Vice President at GE Capital Transportation Finance from 2000 to 2002, Chief Financial Officer at Prasco LLC from 2003 to 2011, Chief Financial Officer at G&W Laboratories, Inc. from 2014 to 2016, Chief Financial & Accounting Officer at electroCore, Inc. from 2018 to 2019, Principal at Gsv Advisory Services, LLC in 2016, Chief Financial Officer at Inversago Pharma, Inc. from 2022 to 2024, CFO-Autonomous Automotive Technology Division at Valeo SE from 2021 to 2022, and Chief Financial Officer at Evaxion AS from 2019 to 2021.
Education includes undergraduate and MBA from Rutgers Center For Management Development.

Cargos activos de Glenn Vraniak

Empresas	Cargo	Inicio
Apollomics, Inc. (United States) Apollomics, Inc. (United States) BiotechnologyHealth Technology Develops mono therapies and combination therapies of tumor-targeting and immuno-oncology agents	Director/Miembro de la Junta	30/03/2023

Todos los cargos activos de Glenn Vraniak

Antiguos cargos conocidos de Glenn Vraniak.

Empresas	Cargo	Fin
APOLLOMICS, INC.	Director/Miembro de la Junta	03/09/2025
Inversago Pharma, Inc. Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops CB1 receptor based therapies for obesity, diabetes and complication treatment	Director Financiero/CFO	01/07/2024
VALEO SE	Corporate Officer/Principal	01/04/2022
EVAXION A/S	Director Financiero/CFO	01/10/2021
ELECTROCORE, INC.	Director Financiero/CFO	01/04/2019

Ver el detalle de la experiencia de Glenn Vraniak.

Formación de Glenn Vraniak.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Glenn Vraniak.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	13
Aprecia Pharmaceuticals Co. Aprecia Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs	Health Technology
Valeo SE Valeo SE Auto Parts: OEMProducer Manufacturing Manufactures and sells visibility, powertrain, thermal and driving systems	Producer Manufacturing
GE Capital Transportation Finance GE Capital Transportation Finance Finance/Rental/LeasingFinance Provides customized leases and secured loan	Finance
Prasco LLC Prasco LLC Pharmaceuticals: GenericHealth Technology Manufactures generic drugs	Health Technology
G&W Laboratories, Inc. G&W Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products	Health Technology
electroCore, Inc. electroCore, Inc. Medical SpecialtiesHealth Technology Develops non-invasive neuromodulation therapies	Health Technology
Evaxion Biotech A/S Evaxion Biotech A/S BiotechnologyHealth Technology Develops novel vaccines	Health Technology
Apollomics, Inc. (United States) Apollomics, Inc. (United States) BiotechnologyHealth Technology Develops mono therapies and combination therapies of tumor-targeting and immuno-oncology agents	Health Technology
Perceptus
Rutgers Center For Management Development Rutgers Center For Management Development Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Gsv Advisory Services, LLC
Inversago Pharma, Inc. Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops CB1 receptor based therapies for obesity, diabetes and complication treatment	Health Technology
Apollomics, Inc. Apollomics, Inc. Financial ConglomeratesFinance Operates as a biotechnology company that focuses on development of novel medicines for cancer patients	Finance